re: Ann: Neuren completes Phase I NNZ2566 stu... What am I taking away from this CA and the timing/lead up to the TAP conference next week?
1. Neuren will continue to pursue development of NNZ-2566 as if they'll never have a deal.
2. Neuren will continue to pursue a deal as if nothing is more important.
3. The main purpose of presenting at the TAP conference is to give a global update on NNZ-2566.
4. If someone puts a deal on the table that’s too good to refuse, i don't believe they will.
5. Neuren's story continues to evolve and strengthen and that’s where they’re putting their energy because it supports both paths.
6. The safety/tolerability, data etc.. are consistently encouraging.
Does that accurately predict the future? No. Does it give them confidence? I'd say it does.
Tony
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren completes Phase I NNZ2566 study/files
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.70%
!
$17.64

Ann: Neuren completes Phase I NNZ2566 study/files, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.64 |
Change
0.630(3.70%) |
Mkt cap ! $2.205B |
Open | High | Low | Value | Volume |
$17.48 | $18.44 | $17.40 | $11.84M | 661.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 66 | $17.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.65 | 35 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 74 | 17.660 |
3 | 203 | 17.650 |
4 | 239 | 17.640 |
3 | 259 | 17.630 |
3 | 265 | 17.620 |
Price($) | Vol. | No. |
---|---|---|
17.670 | 337 | 1 |
17.680 | 89 | 3 |
17.690 | 71 | 2 |
17.700 | 520 | 6 |
17.710 | 252 | 3 |
Last trade - 14.35pm 07/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |